Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 5/20 | 0.94 |
| ▸ | ADH1A | P07327 | 5/20 | 0.94 |
| ▸ | ADH1C | P00326 | 4/20 | 0.94 |
| ▸ | ADH4 | P08319 | 2/20 | 0.94 |
| ▸ | ADH7 | P40394 | 3/20 | 0.89 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2109469 | 0.97 | ADH1B (1.00) | ADH1BADH1AADH1CADH4ADH7 | |
| SCHEMBL645299 | 0.97 | ADH1B (1.00) | ADH1BADH1AADH1CADH4ADH7 | |
| SCHEMBL9206597 | 0.97 | ADH1B (1.00) | ADH1BADH1AADH1CADH4ADH7 | |
| SCHEMBL245391 | 0.97 | ADH1B (1.00) | ADH1BADH1AADH1CADH4ADH7 | |
| SCHEMBL2112448 | 0.97 | ADH1B (1.00) | ADH1BADH1AADH1CADH4ADH7 | |
| SCHEMBL22988657 | 0.97 | ADH1B (1.00) | ADH1BADH1AADH1CADH4ADH7 | |
| Cyclohexylformamide SCHEMBL26146 | 0.97 | — | — | |
| Cyclohexylformamide SCHEMBL28496813 | 0.97 | ADH1B (1.00) | ADH1BADH1AADH1CADH4ADH7 | |
| Cyclohexylformamide SCHEMBL815680 | 0.94 | ADH1B (0.94) | ADH1BADH1AADH1CADH4ADH7 | |
| Cyclohexylformamide SCHEMBL816897 | 0.94 | ADH1B (0.94) | ADH1BADH1AADH1CADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153545-B2 | Process for homo—or copolymerization of conjugated olefins | STYRON EUROPE GMBH (CH) | 2012-04-10 | — | — | US | disclosed |
| US-20110160041-A1 | PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS | STYRON EUROPE GMBH | 2011-06-30 | — | — | US | disclosed |
| US-7915194-B2 | Process for homo- or copolymerization of conjugated olefins | STYRON EUROPE GMBH (CH) | 2011-03-29 | — | — | US | disclosed |
| US-20100248947-A1 | PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-09-30 | — | — | US | disclosed |
| US-7612009-B2 | Process for homo-or copolymerization of conjugated olefines | DOW GLOBAL TECHNOLOGIES, INC. (US) | 2009-11-03 | — | — | US | disclosed |
| US-20060142145-A1 | Process for homo-or copolymerization of conjugated olefines | TRINSEO EUROPE GMBH (CH) | 2006-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160041-A1 | PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS | F12, ETFB, F2 | ADH1B 1366/4885ADH1A 959/4885ADH1C 687/4885 |
| US-20060142145-A1 | Process for homo-or copolymerization of conjugated olefines | ETFB, F12, F2 | ADH1B 970/4885ADH1A 930/4885ADH1C 723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.